Source: BriefingWire

Press Release: Orifarm : Cholelithiasis Global Clinical Trials Review H1 2017

ReportsWeb.com published "Cholelithiasis Market" from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Erik Sandberg's photo - CEO of Orifarm

CEO

Erik Sandberg

CEO Approval Rating

86/100

Read more